Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Cleopatra Hospital Co's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 11.23%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Cleopatra Hospital Co's 5-Year ROIIC % or its related term are showing as below:
CAI:CLHO's 5-Year ROIIC % is ranked better than 67.98% of 534
companies
in the Healthcare Providers & Services industry
Industry Median: 3.33
vs CAI:CLHO: 11.23
Cleopatra Hospital Co (CAI:CLHO) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Cleopatra Hospital Co 5-Year ROIIC % Related Terms
Cleopatra Hospital Co 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Cleopatra Hospital Co's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI:CLHO vs HCA, THC, DVA: 5-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co 5-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Cleopatra Hospital Co (CAI:CLHO) has a 5-Year ROIIC % of 11.23 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Cleopatra Hospital Co and its competitors. According to the industry distribution chart, Cleopatra Hospital Co ranks #171 out of 534 companies in the Healthcare Providers & Services industry, placing it in the top 32%.
Is Cleopatra Hospital Co's 5-Year ROIIC % too high?
Cleopatra Hospital Co's current 5-Year ROIIC % is 11.23. The Healthcare Providers & Services industry median 5-Year ROIIC % is 3.33. Cleopatra Hospital Co's value of 11.23 is 237.2% above this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #171 out of 534 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cleopatra Hospital Co has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's 5-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #171 out of 534 companies for 5-Year ROIIC %. This puts Cleopatra Hospital Co in the upper half of its industry. The industry median 5-Year ROIIC % is 3.33. Cleopatra Hospital Co's value of 11.23 is 237.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.33, based on 534 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current 5-Year ROIIC % of 11.23 is 237.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current 5-Year ROIIC % is 11.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£14.08, compared to a current price of E£16.20 — trading 15.1% above its estimated fair value. The current 5-Year ROIIC % is 11.23 and 237.2% above the Healthcare Providers & Services industry median of 3.33. Cleopatra Hospital Co's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current 5-Year ROIIC % is 11.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£16.20 is trading 15.1% above its estimated GF Value™ of E£14.08.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
5-Year ROIIC %: 11.23
GF Value™: E£14.08 vs. price of E£16.20 (15.1% above fair value)
Industry Position: 237.2% above the Healthcare Providers & Services median (#171 of 534)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
89GF Score
Get the complete analysis for CAI:CLHO
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
